Delineation of target expression profiles in CD34+/CD38− and CD34+/CD38+ stem and progenitor cells in AML and CML
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Delineation of target expression profiles in CD34+/CD38− and CD34+/CD38+ stem and progenitor cells in AML and CML
Authors
Keywords
-
Journal
Blood Advances
Volume 4, Issue 20, Pages 5118-5132
Publisher
American Society of Hematology
Online
2020-10-21
DOI
10.1182/bloodadvances.2020001742
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- IL1RAP potentiates multiple oncogenic signaling pathways in AML
- (2018) Kelly Mitchell et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Abnormal CD25 expression on hematopoietic cells in myelodysplastic syndromes
- (2018) Pei Liu et al. LEUKEMIA RESEARCH
- Leukemic stem cell signatures identify novel therapeutics targeting acute myeloid leukemia
- (2018) Isabelle Laverdière et al. Blood Cancer Journal
- Prospective Isolation and Characterization of Genetically and Functionally Distinct AML Subclones
- (2018) Bauke de Boer et al. CANCER CELL
- Osteogenic niche in the regulation of normal hematopoiesis and leukemogenesis
- (2018) Phuong M. Le et al. HAEMATOLOGICA
- Expression of CD25 on leukemic stem cells in BCR-ABL1 + CML: Potential diagnostic value and functional implications
- (2017) Irina Sadovnik et al. EXPERIMENTAL HEMATOLOGY
- Bone marrow niche-mediated survival of leukemia stem cells in acute myeloid leukemia: Yin and Yang
- (2016) Hong-Sheng Zhou et al. Cancer Biology & Medicine
- Identification of CD25 as STAT5-Dependent Growth Regulator of Leukemic Stem Cells in Ph+ CML
- (2015) I. Sadovnik et al. CLINICAL CANCER RESEARCH
- Clonal evolution of preleukemic hematopoietic stem cells in acute myeloid leukemia
- (2015) Stephen M. Sykes et al. EXPERIMENTAL HEMATOLOGY
- Chronic mast cell leukemia: A novel leukemia-variant with distinct morphological and clinical features
- (2015) Peter Valent et al. LEUKEMIA RESEARCH
- Clinical and Prognostic Implications of Roundabout 4 (Robo4) in Adult Patients with Acute Myeloid Leukemia
- (2015) Yin-Kai Chen et al. PLoS One
- Dipeptidylpeptidase IV (CD26) defines leukemic stem cells (LSC) in chronic myeloid leukemia
- (2014) H. Herrmann et al. BLOOD
- The IL-2/CD25 axis maintains distinct subsets of chronic myeloid leukemia-initiating cells
- (2014) C. I. Kobayashi et al. BLOOD
- Advances in understanding the leukaemia microenvironment
- (2014) Yoko Tabe et al. BRITISH JOURNAL OF HAEMATOLOGY
- Identification of Campath-1 (CD52) as Novel Drug Target in Neoplastic Stem Cells in 5q-Patients with MDS and AML
- (2014) K. Blatt et al. CLINICAL CANCER RESEARCH
- Unique Effects of KIT D816V in BaF3 Cells: Induction of Cluster Formation, Histamine Synthesis, and Early Mast Cell Differentiation Antigens
- (2014) M. Mayerhofer et al. JOURNAL OF IMMUNOLOGY
- Pre-leukemic evolution of hematopoietic stem cells: the importance of early mutations in leukemogenesis
- (2014) M R Corces-Zimmerman et al. LEUKEMIA
- Preleukemic mutations in human acute myeloid leukemia affect epigenetic regulators and persist in remission
- (2014) M. R. Corces-Zimmerman et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Gemtuzumab ozogamicin for treatment of newly diagnosed acute myeloid leukaemia: a systematic review and meta-analysis
- (2013) Mohamed A. Kharfan-Dabaja et al. BRITISH JOURNAL OF HAEMATOLOGY
- Heterogeneity of Neoplastic Stem Cells: Theoretical, Functional, and Clinical Implications
- (2013) P. Valent et al. CANCER RESEARCH
- CD25 expression status improves prognostic risk classification in AML independent of established biomarkers: ECOG phase 3 trial, E1900
- (2012) M. Gonen et al. BLOOD
- Membrane-bound human SCF/KL promotes in vivo human hematopoietic engraftment and myeloid differentiation
- (2012) S. Takagi et al. BLOOD
- The Hsp32 Inhibitors SMA-ZnPP and PEG-ZnPP Exert Major Growth-Inhibitory Effects on D34+/CD38+ and CD34+/CD38- AML Progenitor Cells
- (2012) H. Herrmann et al. CURRENT CANCER DRUG TARGETS
- A Proteomics and Transcriptomics Approach to Identify Leukemic Stem Cell (LSC) Markers
- (2012) Francesco Bonardi et al. MOLECULAR & CELLULAR PROTEOMICS
- Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing
- (2012) Li Ding et al. NATURE
- Dipeptidylpeptidase 4 negatively regulates colony-stimulating factor activity and stress hematopoiesis
- (2012) Hal E Broxmeyer et al. NATURE MEDICINE
- Clonal Evolution of Preleukemic Hematopoietic Stem Cells Precedes Human Acute Myeloid Leukemia
- (2012) M. Jan et al. Science Translational Medicine
- Robo4 Cooperates with Cxcr4 to Specify Hematopoietic Stem Cell Localization to Bone Marrow Niches
- (2011) Stephanie Smith-Berdan et al. Cell Stem Cell
- CD34+/CD38- stem cells in chronic myeloid leukemia express Siglec-3 (CD33) and are responsive to the CD33-targeting drug gemtuzumab/ozogamicin
- (2011) H. Herrmann et al. HAEMATOLOGICA
- Molecular Genetics of Adult Acute Myeloid Leukemia: Prognostic and Therapeutic Implications
- (2011) Guido Marcucci et al. JOURNAL OF CLINICAL ONCOLOGY
- Therapeutic Advances in Acute Myeloid Leukemia
- (2011) Alan Burnett et al. JOURNAL OF CLINICAL ONCOLOGY
- Residual normal stem cells can be detected in newly diagnosed chronic myeloid leukemia patients by a new flow cytometric approach and predict for optimal response to imatinib
- (2011) J J W M Janssen et al. LEUKEMIA
- Gene expression profiling in the leukemic stem cell-enriched CD34+ fraction identifies target genes that predict prognosis in normal karyotype AML
- (2011) H J M de Jonge et al. LEUKEMIA
- The bone marrow microenvironment as a sanctuary for minimal residual disease in CML
- (2010) Rajesh R. Nair et al. BIOCHEMICAL PHARMACOLOGY
- Leukemia-initiating cells from some acute myeloid leukemia patients with mutated nucleophosmin reside in the CD34- fraction
- (2010) D. C. Taussig et al. BLOOD
- Independent prognostic variables in acute myeloid leukaemia
- (2010) Matthew L. Smith et al. BLOOD REVIEWS
- TIM-3 Is a Promising Target to Selectively Kill Acute Myeloid Leukemia Stem Cells
- (2010) Yoshikane Kikushige et al. Cell Stem Cell
- Targeting of Leukemia-Initiating Cells to Develop Curative Drug Therapies: Straightforward but Nontrivial Concept
- (2010) P. Valent CURRENT CANCER DRUG TARGETS
- Nomenclature Evolution: Changes in the ISCN from the 2005 to the 2009 Edition
- (2010) A.R. Brothman et al. CYTOGENETIC AND GENOME RESEARCH
- Association of a Leukemic Stem Cell Gene Expression Signature With Clinical Outcomes in Acute Myeloid Leukemia
- (2010) Andrew J. Gentles JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Targeting leukemic stem cells by breaking their dormancy
- (2010) Marieke Alida Gertruda Essers et al. Molecular Oncology
- Isolation and killing of candidate chronic myeloid leukemia stem cells by antibody targeting of IL-1 receptor accessory protein
- (2010) M. Jaras et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Identification of Therapeutic Targets for Quiescent, Chemotherapy-Resistant Human Leukemia Stem Cells
- (2010) Y. Saito et al. Science Translational Medicine
- Treatment strategies for CML
- (2009) John M. Goldman BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
- Molecular and functional analysis of the stem cell compartment of chronic myelogenous leukemia reveals the presence of a CD34- cell population with intrinsic resistance to imatinib
- (2009) R. M. Lemoli et al. BLOOD
- The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
- (2009) J. W. Vardiman et al. BLOOD
- Interleukin-2 receptor alpha-chain (CD25) expression on leukaemic blasts is predictive for outcome and level of residual disease in AML
- (2009) Monique Terwijn et al. EUROPEAN JOURNAL OF CANCER
- Chronic myelogenous leukemia stem cells: What’s new?
- (2009) Mhairi Copland Current Hematologic Malignancy Reports
- Anti-CD38 antibody-mediated clearance of human repopulating cells masks the heterogeneity of leukemia-initiating cells
- (2008) D. C. Taussig et al. BLOOD
- Emerging stem cell concepts for imatinib-resistant chronic myeloid leukaemia: implications for the biology, management, and therapy of the disease
- (2008) Peter Valent BRITISH JOURNAL OF HAEMATOLOGY
- Identification of Novel Trophoblast Invasion-Related Genes: Heme Oxygenase-1 Controls Motility via Peroxisome Proliferator-Activated Receptor γ
- (2008) Martin Bilban et al. ENDOCRINOLOGY
- Chronic Myeloid Leukemia Stem Cells
- (2008) Edward Kavalerchik et al. JOURNAL OF CLINICAL ONCOLOGY
- Roundabout 4 Is Expressed on Hematopoietic Stem Cells and Potentially Involved in the Niche-Mediated Regulation of the Side Population Phenotype
- (2008) Fumi Shibata et al. STEM CELLS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More